FDA Inspection 1121668 — Tata Consultancy Services Ltd.
The FDA completed an inspection of Tata Consultancy Services Ltd. on February 25, 2020 in Thane West. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- February 25, 2020
- Fiscal Year
- 2020
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Thane West (India)
Additional Details
Sponsor, Contract Research Organization